MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. MapLight Therapeutics (NAS: MPLT) is based in Burlington, MA and was founded in 2018. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $704 million (Oct 2025). It has raised $919 million.
Last price · $/share
—
Implied valuation
$704.3M
Total raised
$919.4M
Last round
—
Team — not yet on record
No current team members for MapLight Therapeutics (NAS: MPLT) are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of MapLight Therapeutics (NAS: MPLT) with a free account
·Watch MapLight Therapeutics (NAS: MPLT): the Monday email on marks, rounds and moves
